| The genomic history of southeastern Europe I Mathieson, S Alpaslan-Roodenberg, C Posth, A Szécsényi-Nagy, ... Nature 555 (7695), 197-203, 2018 | 720 | 2018 |
| Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor A Hobisch, IE Eder, T Putz, W Horninger, G Bartsch, H Klocker, Z Culig Cancer research 58 (20), 4640-4645, 1998 | 565 | 1998 |
| Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy CS Thaxton, R Elghanian, AD Thomas, SI Stoeva, JS Lee, ND Smith, ... Proceedings of the National Academy of Sciences 106 (44), 18437-18442, 2009 | 457 | 2009 |
| Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria G Bartsch, W Horninger, H Klocker, A Reissigl, W Oberaigner, ... Urology 58 (3), 417-424, 2001 | 429 | 2001 |
| Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection FH Jansen, RHN van Schaik, J Kurstjens, W Horninger, H Klocker, ... European urology 57 (6), 921-927, 2010 | 332 | 2010 |
| Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores AP Berger, C Gozzi, H Steiner, F Frauscher, J Varkarakis, H Rogatsch, ... The Journal of urology 171 (4), 1478-1481, 2004 | 323 | 2004 |
| 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour C Uprimny, AS Kroiss, C Decristoforo, J Fritz, E von Guggenberg, ... European journal of nuclear medicine and molecular imaging 44, 941-949, 2017 | 315 | 2017 |
| 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ... European journal of nuclear medicine and molecular imaging 42, 1284-1294, 2015 | 309 | 2015 |
| Real‐time elastography for detecting prostate cancer: preliminary experience L Pallwein, M Mitterberger, P Struve, G Pinggera, W Horninger, G Bartsch, ... BJU international 100 (1), 42-46, 2007 | 255 | 2007 |
| Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml WJ Catalona, G Bartsch, HG Rittenhouse, CL Evans, HJ Linton, ... The Journal of urology 170 (6), 2181-2185, 2003 | 249 | 2003 |
| Long‐term morbidity and mortality of transurethral prostatectomy: a 10‐year follow‐up J Varkarakis, G Bartsch, W Horninger The Prostate 58 (3), 248-251, 2004 | 248 | 2004 |
| Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection F Frauscher, A Klauser, H Volgger, EJ Halpern, L Pallwein, H Steiner, ... The Journal of urology 167 (4), 1648-1652, 2002 | 247 | 2002 |
| Transurethral prostatectomy: mortality and morbidity W Horninger, H Unterlechner, H Strasser, G Bartsch The Prostate 28 (3), 195-200, 1996 | 220 | 1996 |
| Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen WJ Catalona, G Bartsch, HG Rittenhouse, CL Evans, HJ Linton, ... The Journal of urology 171 (6 Part 1), 2239-2244, 2004 | 216 | 2004 |
| The proximal neurovascular plate and the tri‐zonal neural architecture around the prostate gland: importance in the athermal robotic technique of nerve‐sparing prostatectomy A Tewari, A Takenaka, E Mtui, W Horninger, R Peschel, G Bartsch, ... BJU international 98 (2), 314-323, 2006 | 206 | 2006 |
| Proenzyme PSA for the early detection of prostate cancer in the 2.5–4.0 ng/ml total PSA range: preliminary analysis LJ Sokoll, DW Chan, SD Mikolajczyk, HG Rittenhouse, CL Evans, ... Urology 61 (2), 274-276, 2003 | 186 | 2003 |
| Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy A Pelzer, J Bektic, AP Berger, L Pallwein, EJ Halpern, W Horninger, ... The Journal of urology 173 (6), 1926-1929, 2005 | 178 | 2005 |
| Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial AW Partin, MK Brawer, G Bartsch, W Horninger, SS Taneja, H Lepor, ... The Journal of urology 170 (5), 1787-1791, 2003 | 170 | 2003 |
| Detection of prostate cancer with a microbubble ultrasound contrast agent F Frausher, EJ Halpern, W Horninger, G Bartsch The lancet 357 (9271), 1849-1850, 2001 | 168 | 2001 |
| Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score M Mitterberger, GM Pinggera, W Horninger, G Bartsch, H Strasser, ... The Journal of urology 178 (2), 464-468, 2007 | 165 | 2007 |
